WATERS CORP /DE/ WAT
NYSE · XNYS · stock · Laboratory Analytical Instruments
Chart by TradingView
4/9
Piotroski F — financial health
10
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.2B | $642.6M | — | — | $2.6B |
| 2024 | $3.0B | $637.8M | — | — | $1.8B |
| 2023 | $3.0B | $642.2M | — | — | $1.2B |
| 2022 | $3.0B | $707.8M | — | — | $504.5M |
| 2021 | $2.8B | — | — | — | $367.6M |
| 2020 | $2.4B | — | — | — | $232.1M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 10 (safe)
- Working capital / assets 0.179
- Retained earnings / assets 2.055
- EBIT / assets 0.158
- Equity / liabilities 1.019
Source: SEC EDGAR filings · CIK 0001000697 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.